Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Milestone Pharmaceuticals enrolls first European patient in Phase 3 trial
Milestone Pharmaceuticals said the first European patient has been enrolled in its ReVeRA-301 Phase 3 trial of etripamil nasal spray for AFib-RVR. The company said enrollment is advancing toward a target of about 150 patients.
Milestone Pharmaceuticals enrolls first European participant in ReVeRA-301 Phase 3
Milestone Pharmaceuticals announced the first European study participant has been enrolled in its ReVeRA-301 Phase 3 clinical trial.